胃肠安丸
Search documents
津药达仁堂全程守护 数字环驾中国大赛30天征程破万
Zhong Guo Jin Rong Xin Xi Wang· 2025-12-17 09:09
编辑:穆皓 在这场跨越山河的极限征途中,津药达仁堂以传承五百年的中医药智慧,为车手们打造移动的 "健康守护站"。针对旅途常见不适,量身定制的健康包涵盖 速效救心丸、清咽滴丸、胃肠安丸、藿香正气软胶囊、京万红软膏以及风油精等多款经典国药,从呼吸、消化、急救、外用等多个维度,全方位守护车手们 的征途健康。在广东省湛江市南三岛的高温中突然的胸闷气短,含服速效救心丸后有所舒缓,休息片刻便继续前行;穿越甘肃省张掖市大地之树峡谷时长时 间干燥引发的喉咙干痒刺痛,含上清咽滴丸后疼痛减弱,继续向前奔赴下一站。 当数字科技赋能汽车赛事,当无畏探索遇上国药守护,津药达仁堂集团以现代中药的专业力量,让车手们得以心无旁骛挑战极限、逐梦山河。每一公里的驰 骋,都是科技与勇气的双重彰显;每一次的突破,都离不开专业守护的坚实支撑。这场破万里程的数字环驾之旅,既展现了中国汽车产业的硬核科技实力, 更书写了五百年中医药与现代赛事的跨界相融新篇章。以国药之力护航征途,以敬畏之心丈量中国,"2025 中国数字汽车大赛・数字环驾中国大赛" 的精彩 仍在继续,更多山河盛景与挑战突破,值得共同期待!(李禹霏) 转自:新华财经 2025年11月17日," ...
研报掘金丨国海证券:首予达仁堂“买入”评级,看好公司长期成长性
Ge Long Hui A P P· 2025-08-19 06:19
Core Viewpoint - Guohai Securities report indicates that Darentang's core product revenue is growing steadily, and the company is expected to have long-term growth potential [1] Financial Performance - In the first half of 2025, the company achieved operating revenue of 2.651 billion yuan, with industrial main revenue of 2.645 billion yuan, representing a year-on-year increase of 0.87% [1] - Sales revenue of the fast-acting rescue heart pill (including tax) reached 1.128 billion yuan, with a year-on-year growth of 5.45% [1] - Sales revenue of the throat-clearing pill (including tax) was 289 million yuan, showing a significant year-on-year increase of 52.28% [1] Strategic Initiatives - The company is actively promoting the Darentang Fast-Acting Rescue Heart Public Welfare Action and conducting promotional activities for the throat-clearing pill [1] - Initiatives such as the "Skin Health Theme Sales Project" and "Darentang Gastrointestinal Health China Tour" are being implemented for products like Jingwanhong and Weichang Anwan [1] - The company is accelerating the expansion of new retail channels, utilizing a dual-driven approach of B2C and O2O to explore new growth paths [1]